ARCHIVES

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994

Excerpts From Potti’s Application to Practice Medicine In South Carolina

December 9, 2011

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995

Black Physicians, Community Group To work With NCI

April 21, 1989

Rose Kushner, Author, Advocate, Dead At 60 Of Breast Cancer

January 19, 1990

Low Budget, Empty Beds, Lack Of Vision Beset Clinical Center, NIH Officials Say.

June 20, 2008